Belluscura Announces Strategic Review

UNITED KINGDOM—Portable oxygen concentrator (POC) maker Belluscura announced that it has begun a strategic review with the goal of generating new capital.

The company said that the U.S. import tariff on its portable oxygen containers remains at zero, pending any new changes. The company said this tariff number continues to support Belluscura’s cost structure and reinforces its ability to offer competitively priced products.

Despite challenges in late February and March in sourcing product, the company said it experienced renewed demand for the X-PLOR POC during April and said that demand remains robust due to a growing need for portable oxygen solutions globally. The full commercial launch of its new DISCOV-R POC remains on track and is expected towards the end of the third quarter, officials said.

Belluscura said that its principal constraint towards achieving profitability is access to sufficient working capital to fund bulk orders of completed goods, as bulk ordering is a key factor in significantly reducing the unit cost of goods sold. To address this, the company has initiated a strategic review, which will evaluate a range of options to substantially strengthen its capital position, including potential strategic investment, partnerships, alternative funding structures and other corporate initiatives. The review is aimed at supporting both the company’s short-term cash requirements and its longer-term growth and accelerating its path to sustainable profitability.